DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Naltrexone (Naltrexone Hydrochloride) - Current Clinical Trials


Naltrexone Related Clinical Trials

Naltrexone for Heavy Drinking in Young Adults [Completed]

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease [Completed]

Low Dose Naltrexone for Glioma Patients [Completed]

Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse. [Completed]

Naltrexone and Hypoglycemia in Type 1 Diabetes [Completed]

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence [Completed]

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder [Terminated]

Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care [Recruiting]

Improved Strategies for Outpatient Opioid Detoxification [Recruiting]

Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence [Recruiting]

Effects of Naltrexone on Nicotine Reinforcement [Completed]

Naltrexone for Individuals of East Asian Descent [Recruiting]

The Effects of Naltrexone on Active Crohn's Disease [Completed]

Dronabinol Naltrexone Treatment for Opioid Dependence [Completed]

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site [Active, not recruiting]

Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder [Completed]

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors [Recruiting]

Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease [Withdrawn]

Control of Cognition [Recruiting]

Pilot Study of Depot NTX in Homeless Veterans [Terminated]

The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients [Not yet recruiting]

Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM [Recruiting]

Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study. [Completed]

A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery [Active, not recruiting]

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment [Recruiting]

Naltrexone Treatment for Alcoholic Women [Completed]

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations [Recruiting]

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (Mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers [Completed]

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence [Recruiting]

Managing Alcoholism in People Who Do Not Respond to Naltrexone [Completed]

Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers [Completed]

ALK21-004: Single-dose Opiate Challenge of Medisorb« Naltrexone (VIVITROL«) in Adults Who Use Opioids [Completed]

Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors [Recruiting]

Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects [Completed]

Low-Dose Naltrexone for Depression Relapse and Recurrence [Completed]

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence [Completed]

Naltrexone Treatment of Alcohol Abuse in Schizophrenia [Completed]

ALK21-003: Study of Medisorb« Naltrexone (VIVITROL«) in Alcohol-Dependent Adults [Completed]

Targeted Naltrexone for Problem Drinkers [Completed]

Trial of Naltrexone and Dextromethorphan for Gulf War Illness [Recruiting]

ALK21-006EXT: Long-term Safety of Medisorb« Naltrexone (VIVITROL«) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) [Terminated]

Adherence to HIV Therapy in Heroin Addicts [Not yet recruiting]

Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence [Completed]

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Withdrawn]

Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT [Completed]

Investigation of Naltrexone for Pathological Gambling [Active, not recruiting]

An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence [Completed]

Naltrexone in Treating Women With Metastatic Breast Cancer That Did Not Respond to Hormone Therapy [Terminated]

Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain [Completed]

Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway [Recruiting]

Efficacy of Naltrexone in Women's Smoking Cessation [Completed]

Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services [Completed]

Understanding Treatment Response With Naltrexone Among White Alcoholics [Completed]

Naltrexone for Antipsychotic-Induced Weight Gain [Recruiting]

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users [Not yet recruiting]

Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain [Completed]

ALK21-010: Long-term Safety of Medisorb« Naltrexone (VIVITROL«) in Alcohol-dependent Adults [Completed]

Extended-release Naltrexone for Alcohol Dependence in Primary Care [Completed]

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 [Completed]

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ [Completed]

Alcohol Use Disorder hOsPital Treatment Trial [Not yet recruiting]

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone [Recruiting]

N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence [Completed]

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) [Completed]

ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb« Naltrexone (VIVITROL«) [Completed]

Biomarkers of Injectable Extended Release Naltrexone Treatment [Enrolling by invitation]

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry [Recruiting]

Naltrexone & SSRI in Alcoholics With Depression/PTSD [Active, not recruiting]

An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. [Recruiting]

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) [Recruiting]

Double-Blind Naltrexone in Compulsive Sexual Behavior [Completed]

Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts [Completed]

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial [Terminated]

Study of Naltrexone for Methamphetamine Addiction [Completed]

Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects [Completed]

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer [Recruiting]

Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer [Terminated]

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia [Recruiting]

The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse [Active, not recruiting]

Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment [Recruiting]

Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. [Completed]

A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users [Completed]

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence [Recruiting]

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects [Completed]

Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) [Completed]

ALK21-021: A Safety Study of Medisorb« Naltrexone (VIVITROL«) Administered to Health Care Professionals [Completed]

ALK21-014: Efficacy and Safety of Medisorb´┐Ż Naltrexone (VIVITROL´┐Ż) After Enforced Abstinence [Completed]

A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Terminated]

Naltrexone for Impulse Control Disorders in Parkinson's Disease [Completed]

Cocaine Use Reduction With Buprenorphine [Completed]

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone [Completed]

Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone [Active, not recruiting]

Extended Release Naltrexone for Opioid-Dependent Youth [Recruiting]

Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland [Completed]

Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence [Completed]

Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone [Completed]

Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence [Completed]

Addiction Treatment in Russia: Oral vs. Naltrexone Implant [Completed]

Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017